01/13/2026 | Press release | Distributed by Public on 01/13/2026 11:30
Experts can discuss what the 70% five-year survival milestone means for patients, future of research
Ben Schamisso
CHICAGO --- Northwestern University oncologists are available for print and broadcast interviews today following the release of the American Cancer Society's 2026 statistics report, which shows that, for the first time, 70% of people diagnosed with cancer in the U.S. survive at least five years.
The report highlights especially large survival gains for some of the deadliest cancers, including myeloma, liver cancer and lung cancer, reflecting advances in lifestyle change, early detection, research and targeted therapies.
Contact Ben Schamisso at [email protected] to schedule an interview.
Quote from Dr. Leonidas Platanias, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University:
"This is a major improvement from the past and the outcome of important cancer research. The challenge is now how we can get the same outcome for the remaining 30% of patients, and how we can do that as soon as possible."
Quote from Dr. Mohamed Abazeed, chair and professor of radiation oncology at Northwestern University Feinberg School of Medicine:
"Behind every statistic in this report is a person, a family and a life reshaped by cancer. The progress we're seeing is real, and it exists because of decades of sustained investment in cancer research that has led to earlier detection, more effective treatments and more personalized care. Critically, as more patients survive cancer, success must be measured not just in years added, but in the quality of those years. Our responsibility now is to keep going. Continued support for research is not optional; it's the reason these gains are possible, and it's how we ensure that every patient has a chance at a longer, fuller life."
Quote from Dr. Sean Sachdev, associate professor of radiation oncology at Northwestern University Feinberg School of Medicine:
"Five-year survival across many cancer types continues to improve, thanks to advances in treatment, scientific research and carefully designed clinical trials. The report also underscores the critical role of prevention and early detection. Screening for breast and prostate cancers before symptoms appear leads to better outcomes, while healthy choices, like avoiding tobacco, have driven down associated head and neck cancers. Other (HPV-related) head and neck cancers respond far better to treatment today - and with broader HPV vaccination, outcomes could improve even more. These trends show that research, prevention and smart lifestyle decisions truly save lives."